|
03 Apr 2025 |
Balaji Amines
|
Consensus Share Price Target
|
1259.95 |
1640.00 |
- |
30.16 |
buy
|
|
|
|
|
23 Jul 2018
|
Balaji Amines
|
HDFC Securities
|
1259.95
|
748.00
|
525.95
(139.56%)
|
|
Buy
|
|
|
We maintain our Buy rating on Balaji Amines and value BLA at 17.0xJune'21 EPS with a revised target price of Rs 748/share. Balaji Amines (BLA IN) has been able to sustain its earnings momentum after a stellar FY18 performance. Sales/EBITDA/PAT grew by 30.0/44.6/48.6% YoY to Rs 2.6bn/Rs 587mn/Rs 338mn respectively. BLA has relentlessly worked upon growing its volumes on the back of de-bottlenecking exercises, import substitution opportunities and anti-dumping duties in place.
|
|
16 May 2018
|
Balaji Amines
|
HDFC Securities
|
1259.95
|
725.00
|
634.00
(98.73%)
|
|
Buy
|
|
|
We maintain Buy on Balaji Amines and value BLA at 17.0x FY20E EPS with a target price of Rs 725/share. Balaji Amines (BLA) reported a strong 4QFY18 with Sales/EBITDA/PAT growing by 33.0%/23.3%/93.4% YoY to Rs 2.56 bn/ Rs 469 mn/ Rs 332 mn respectively. Sales growth of 33.0%, was driven by 10.0% volume growth
|
|
20 Feb 2018
|
Balaji Amines
|
Edelweiss
|
1259.95
|
797.00
|
658.00
(91.48%)
|
|
Buy
|
|
|
BAL has steadily built up capacity in methylamines and other specialty chemicals between FY10-FY14 riding on the strong demand potential from its key end-user industries - pharmaceuticals...
|
|
09 Nov 2017
|
Balaji Amines
|
Edelweiss
|
1259.95
|
764.00
|
562.70
(123.91%)
|
Target met |
Buy
|
|
|
Balaji Amines (BAL) has steadily built up capacity in methylamines and other specialty chemicals between FY10-FY14 riding on the strong demand potential from its key end-user...
|